| Date |
Research Question / Title |
Unique ID |
Research Team |
|
June 7, 2022
|
What is the efficacy of a 4th booster dose for COVID-19?
|
EOC220304v002 RR
|
EOC
|
|
June 6, 2022
|
What is known about hybrid immunity to COVID-19?
|
INF220501 RR
|
Infectious Disease
|
|
May 27, 2022
|
What is the evidence on timing and outcomes of elective surgery after a COVID infection?
|
EOC220504 RR
|
EOC
|
|
May 24, 2022
|
When should post-COVID infected patients receive booster shots?
|
EOC220503 RR
|
EOC
|
|
May 10, 2022
|
Is there an optimal interval between the administration of COVID-19 early intervention therapeutic products and COVID-19 vaccination?
|
EOC220501 RR
|
EOC
|
|
May 2022
|
Motivational Interviewing for Vaccine Hesitancy - Situation, Background, Assessment, Recommendation (SBAR)
|
EOC220301 SBAR
|
EOC
|
|
March 10, 2022
|
What is the safety/efficacy of the Novavax COVID-19 vaccine?
|
EOC220302 RR
|
EOC
|
|
February 10, 2022
|
What are the latest health policy definitions of being fully vaccinated?
|
EOC220101 RR
|
EOC
|
|
February 4, 2022
|
Is there evidence that children under 18 should receive the booster to increase their immunity?
|
EOC220102 RR
|
EOC
|
|
February 4, 2022
|
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
|
EOC220103 RR
|
EOC
|
|
December 26, 2021
|
How effective are COVID-19 vaccines? [Evergreen]
|
INF031801v019 RR
|
Infectious Disease
|
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 RR
|
EOC
|
|
August 24, 2021
|
What are other jurisdictions offering for incentive-based COVID-19
vaccine campaigns?
|
EOC210501v2 RR
|
EOC
|
|
August 17, 2021
|
What are the causes of vaccine hesitancy? What programs/approaches have been successful in reducing vaccine hesitancy?
|
EOC012201v3 RR
|
EOC
|
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|
|
June 10, 2021
|
What are legitimate exemptions/contraindications for COVID-19 vaccines from a medical point of view?
|
EOC210502 RR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
March 30, 2021
|
What are the effects of the new COVID variants on transmission and school reopenings in pediatric populations?
|
PH030801 RR
|
Public Health
|
|
March 29, 2021
|
What impact does COVID-19 vaccination have on visitation policies and transmission rates in LTC?
|
LTC012501 RR
|
Long Term Care
|
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
